Regeneron Pharmaceuticals is a leading biotechnology company that discovers, develops, and commercializes medicines for serious diseases.
Overview
History And Founding
Research And Development
Key Products And Innovations
Corporate Social Responsibility
Partnerships And Collaborations
Future Directions And Challenges
Impact On Medicine And Healthcare
Clinical Trials And Regulatory Approval
Organization
Technology
Community
Medicine
Diabetes
Science
Cancer
Sanofi
People
๐ Regeneron Pharmaceuticals was founded in 1988 by Leonard Schleifer and Eric Shooter.
๐งฌ The company is known for its innovative monoclonal antibody therapies.
๐ Regeneron operates primarily from Tarrytown, New York.
๐ In recent years, Regeneron has become one of the top biopharmaceutical companies in the U.S.
๐ Their blockbuster drug, Eylea, is used to treat various eye diseases.
๐ฌ Regeneron also developed the COVID-19 monoclonal antibody treatment, REGN-COV2.
๐งช The company invests heavily in research and development, spending over 20% of its revenue on R&D.
๐ค Regeneron collaborates with various academic institutions and organizations to enhance research efforts.
๐ They have received multiple accolades for their scientific contributions and workplace culture.
๐ฑ The company's mission is to use science to bring new medicines to patients in need.